ABSTRACT
INTRODUCTION: The Coronavirus disease 2019 (COVID-19) caused many problems in the health sector. Effective and safe vaccines are the only tool to combat the COVID-19 disease. Researchers and regulatory agencies have made efforts to develop such vaccines and healthcare professionals were prioritized for the vaccination program as first-line care providers. Considering this prioritization, we aimed to assess the physicians' perceptions regarding the side effects of the COVID-19 vaccine. METHODS: An interview-based study was conducted from May 5 May to November 5, 2021 (6 months) in a teaching hospital in the capital city of Islamabad, Pakistan. RESULTS: Among the 200 physicians who agreed to participate in the interview, 74% were male. A total of 94% did not experience any side effects after receiving the COVID-19 vaccine, regardless of the type of vaccine; 6% experienced side effects. Furthermore, 90% of physicians were afraid of side effects due to the high number of vaccine doses. CONCLUSION: Conclusively, physicians had a positive perception regarding the COVID-19 vaccine. Healthcare authorities and related departments must take precautions to ensure the effective and safe COVID-19 vaccine to change the perceptions of physicians who had a negative perception. This will not only reduce the reluctance among physicians regarding administering COVID-19 vaccine, but will also boost and facilitate the vaccination program for the general public as well.
ABSTRACT
Background: Amid the turbulent nature of the COVID-19 pandemic, telepharmacy has shifted the paradigm of patient care by leveraging digital medicine. Government mandated lockdowns and norms of social distancing have further underscored the need for telepharmacy. Many developed and developing countries implemented such initiatives where pharmacists have provided tele-pharmacy services via telecommunications. However, the implementation and utilization of tele-pharmacy services are quite negligible in resource limited settings due to financial and administrative constraints. This study was aimed to ascertain the perception and readiness of pharmacists working in various sectors of a resource limiting country. Methodology: A cross sectional study was carried out in all provinces of Pakistan to explore the perceptions of pharmacists towards telepharmacy implementation through a 35-items study instrument. The collected data was analyzed descriptively and scored accordingly. The chi-square test was used for inferential analysis on pharmacist's perception regarding implementation of tele-pharmacy with their demographics. Results: Of 380 pharmacists, the mean age is 27.67 ± 3.67 years with a preponderance of male pharmacists (n = 238, 62.6%). The pharmacists (n = 321, 84.5%) perceived that telepharmacy implementation improves patient's quality of life and decreases patients' visits (n = 291, 76.6%). Overall, pharmacists (n = 227, 59.7%) had negative perception towards benefits of telepharmacy implementation, but pharmacists had positive perception towards eligibility (n = 258, 67.9%), regulatory issues (n = 271, 71.3%) and telepharmacy during pandemic and beyond (n = 312, 82.1%). In chi-square testing gender (p = 0.03) and age (p = 0.03) had a significant association with perception regarding regulatory issues. Among perception regarding telepharmacy during COVID-19 pandemic and beyond age had a significant association (p = 0.03). Among perception regarding eligibility job location of pharmacists had significant association (p = 0.04). Conclusion: The majority of pharmacists had a positive perception regarding the eligibility of patients and regulatory issues/legal framework regarding the implementation of tele-pharmacy, as well as its use during the COVID-19 pandemic and beyond. The implementation of tele-pharmacy can play a major role in providing timely and better patient care to remote patient areas and may help in the prevention and treatment of different infectious diseases.
ABSTRACT
The growing demand for rare earth elements (REEs) confronted with a parallel supply risk, draws major interest to utilize secondary resources bearing higher REE content than the primary resources. The European Commission has recently identified bauxite as a Critical Raw Material (CRM). In particular, unexploited bauxite residues have invited due attention owing to their abundance (worldwide generation at 120 – 150 million tons/yr) and presence of REEs (0.5 - 1.7 kg/ton) and scandium (Sc) in particular, with Fe: 14–45%, Al: 5–14%, Si: 1–9%, Na: 1–6% and Ti: 2–12%. Nevertheless, it has also to be taken into consideration that higher amassing of this waste is turning into a global concern due to its hazardous impacts and disposal issues owing to its high alkalinity, fine particle size and metal content. Industrial valorization of REEs from stockpiled bauxite residues could possibly unlock approximately a 4.3 trillion-dollar economy globally. This review foresees bauxite as a potential resource for REEs and identifies the problems associated with disposal of bauxite residues. Considering the recycling potential of bauxite residues for supplying valuable metals for technology, biotechnology is seen as a promising alternative to the conventional methods. Comprehensive details including role and challenges of biotechnology in green recovery of REEs from bauxite residues, their scale-up and environmental issues are critically discussed. Furthermore, w.r.t. the bauxite residues, the REE market potential is presented with discussions into future prospects, following the current impact of COVID-19 pandemic on the demand and supply of REE to industrial sectors.